In Brief: Matrix AccuSite
Executive Summary
Matrix AccuSite: Savage Labs will market the injectable flouroracil gel for treatment of genital warts to dermatologists and obstetricians in the U.S. and will retain 30% to 50% of sales. AccuSite is under review at FDA after receiving a "not approvable" letter in December...